» Articles » PMID: 21906921

Plasma Cytokines, Glomerular Filtration Rate and Adipose Tissue Cytokines Gene Expression in Chronic Kidney Disease (CKD) Patients

Overview
Publisher Elsevier
Date 2011 Sep 13
PMID 21906921
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: Systemic inflammation is a hallmark of chronic kidney disease (CKD) and obesity represents a major risk factor for CKD. We investigated the relationship between plasma interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) and the glomerular filtration rate (GFR) in 75 stage 2-5 CKD patients.

Methods And Results: We studied the steady-state relationship between plasma and subcutaneous adipose tissue (SAT) gene expression of the same cytokines in 19 patients and in 17 well-matched healthy subjects (HS) and compared SAT gene expression of these cytokines and of two additional cytokines (IL-1β and IL-8) in CKD patients and in HS. Plasma IL-6 and TNF-α were higher in CKD patients than in HS (P < 0.001). IL-6 was similarly increased in patients with mild, moderate and severe CKD and largely independent of the GFR (r = -0.03, P = NS). TNF-α was inversely related to GFR, which was the first factor in rank (β = -0.37, P = 0.001) explaining the variability in TNF-α in CKD. SAT messenger RNA (mRNA) levels of IL-6, TNF-α, IL- β and IL-8 were similar in CKD patients and in HS. Plasma and SAT mRNA levels of IL-6 and TNF-α levels were largely unrelated.

Conclusions: Plasma IL-6 rises early in CKD and does not show any further increase at more severe stages of CKD, whereas TNF-α is inversely associated with the GFR indicating a substantial difference in the dynamics of the relationship between these cytokines and renal function. Cytokines are not overexpressed in SAT in these patients, and circulating IL-6 and TNF-α are dissociated from the corresponding mRNA levels in SAT, both in CKD patients and in HS.

Citing Articles

Sarcopenia in Chronic Kidney Disease: A Narrative Review from Pathophysiology to Therapeutic Approaches.

Tsai C, Wang P, Hsiung T, Fan Y, Wu J, Kan W Biomedicines. 2025; 13(2).

PMID: 40002765 PMC: 11852367. DOI: 10.3390/biomedicines13020352.


Dietary Patterns, Kidney Function, and Sarcopenia in Chronic Kidney Disease.

Kim J, Yang S Nutrients. 2025; 17(3).

PMID: 39940262 PMC: 11821004. DOI: 10.3390/nu17030404.


Pathogenesis of Sarcopenia in Chronic Kidney Disease-The Role of Inflammation, Metabolic Dysregulation, Gut Dysbiosis, and microRNA.

Bakinowska E, Olejnik-Wojciechowska J, Kielbowski K, Skoryk A, Pawlik A Int J Mol Sci. 2024; 25(15).

PMID: 39126043 PMC: 11313360. DOI: 10.3390/ijms25158474.


Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction.

Matsuoka T, Abe M, Kobayashi H Int J Mol Sci. 2024; 25(7).

PMID: 38612557 PMC: 11012052. DOI: 10.3390/ijms25073745.


The cardio-renal-metabolic connection: a review of the evidence.

Marassi M, Fadini G Cardiovasc Diabetol. 2023; 22(1):195.

PMID: 37525273 PMC: 10391899. DOI: 10.1186/s12933-023-01937-x.